AngioDynamics

AngioDynamics Depreciation & Amortization

The Depreciation & Amortization of AngioDynamics (ANGO) as of Sep 20, 2026 is 10.32 M USD. In the previous year, Depreciation & Amortization was 13.05 M USD — a change of -20.92% (lower).

Depreciation & Amortization

10.32 MUSD

YoY

-20.92%

Last updated:

Depreciation & Amortization of AngioDynamics is 2026 10.32 M USD. Depreciation & Amortization of AngioDynamics was 2025 13.05 M USD. It decreases by -20.92% lower compared to the previous year.

The AngioDynamics Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2018
13.90 M USD
Jan 1, 2019
17.10 M USD
Jan 1, 2020
18.10 M USD
Jan 1, 2021
18.10 M USD
Jan 1, 2022
19.50 M USD
Jan 1, 2023
18.80 M USD
Jan 1, 2024
13.05 M USD
Jan 1, 2025
10.32 M USD
The AngioDynamics Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
10.32 MUSD-20.92%
13.05 MUSD-30.60%
18.80 MUSD-3.59%
19.50 MUSD+7.73%
18.10 MUSD0.00%
18.10 MUSD+5.85%
17.10 MUSD+23.02%
13.90 MUSD-4.79%
14.60 MUSD-18.89%
18.00 MUSD0.00%
18.00 MUSD+8.43%
16.60 MUSD
Access this data via the Eulerpool API

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AngioDynamics stock

Depreciation & Amortization of AngioDynamics is 10.32 M USD in 2026.

Depreciation & Amortization of AngioDynamics changed from 13.05 M USD to 10.32 M USD, representing a -20.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's AngioDynamics historically and in real time.

Access this data via the Eulerpool API

Income Statement — AngioDynamics

All Key Metrics — AngioDynamics